Cholesterol & Saturated Fat Risk Panel
- $464.00
- $132
- Save: 71.55%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Apolipoprotein B
Glucose
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
Hemoglobin A1c
Also known as: LFTs, Liver Function Tests, Liver Panel
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Direct
Bilirubin, Indirect
Bilirubin, Total
Globulin
Protein, Total
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
The Cholesterol & Saturated Fat Risk Panel panel contains 6 tests with 20 biomarkers .
Overview of the Cholesterol & Saturated Fat Risk Panel
The Cholesterol & Saturated Fat Risk Panel is a targeted diagnostic tool designed to evaluate how dietary cholesterol and saturated fat intake may impact cardiovascular and metabolic health. This panel provides a comprehensive assessment of lipid status, inflammation, liver function, and blood sugar control—all of which are critical for determining an individual's risk of developing heart disease, atherosclerosis, or metabolic syndrome.
While moderate consumption of cholesterol and saturated fat may not pose significant health risks for everyone, individuals with certain metabolic profiles, genetic predispositions, or lifestyle factors may experience negative effects such as elevated LDL cholesterol, increased ApoB particle counts, or heightened systemic inflammation. The Cholesterol & Saturated Fat Risk Panel helps uncover these risk factors by evaluating key biomarkers that influence cardiovascular health and fat metabolism.
When and Why the Cholesterol & Saturated Fat Risk Panel May Be Ordered
Healthcare providers may recommend the Cholesterol & Saturated Fat Risk Panel for individuals who:
-
Consume diets high in cholesterol or saturated fat and want to assess their impact on health
-
Have a family history of heart disease, high cholesterol, or stroke
-
Show elevated LDL cholesterol or triglycerides on prior tests
-
Have metabolic risk factors such as obesity, insulin resistance, or diabetes
-
Experience unexplained fatigue, weight gain, or liver enzyme elevations
-
Are interested in developing a personalized dietary strategy for cardiovascular risk reduction
This panel is especially useful for people transitioning to diets that include higher amounts of saturated fat (e.g., ketogenic or low-carb diets) to determine whether such dietary patterns are compatible with their individual health profile.
What the Cholesterol & Saturated Fat Risk Panel Checks For
The Cholesterol & Saturated Fat Risk Panel includes six essential tests that evaluate lipid metabolism, inflammation, blood sugar control, and liver health. Each marker provides critical insight into how saturated fat and cholesterol intake may influence overall cardiovascular and metabolic function.
Apolipoprotein B (ApoB)
ApoB is a protein present in all atherogenic lipoproteins, including LDL, IDL, and VLDL particles. Elevated ApoB levels indicate a higher number of cholesterol-rich particles circulating in the bloodstream, which can penetrate arterial walls and contribute to plaque formation. ApoB is a stronger predictor of cardiovascular disease risk than LDL cholesterol alone, making it essential for assessing the true impact of saturated fat intake on heart health.
Glucose
Fasting glucose measures blood sugar levels at a single point in time. Chronic elevation of fasting glucose indicates impaired carbohydrate metabolism or early insulin resistance. Elevated glucose is a major contributor to metabolic syndrome and increases cardiovascular risk, particularly when combined with high saturated fat intake.
Hemoglobin A1c (HgbA1C)
Hemoglobin A1c provides an average measure of blood glucose control over the past 2–3 months. High A1C levels suggest chronic hyperglycemia, which accelerates oxidative stress and arterial damage, compounding the risk associated with elevated cholesterol or ApoB.
Hepatic Function Panel
This test evaluates liver enzymes and proteins such as ALT, AST, bilirubin, and albumin. The liver plays a critical role in cholesterol synthesis and fat metabolism, so monitoring liver health is essential when dietary fat intake is increased. Abnormal results may indicate non-alcoholic fatty liver disease or impaired fat processing.
hs-CRP (High-Sensitivity C-Reactive Protein)
hs-CRP is a highly sensitive marker of systemic inflammation. Elevated hs-CRP is associated with atherosclerosis and plaque instability, increasing the likelihood of cardiovascular events. Even with normal cholesterol levels, inflammation detected by hs-CRP may indicate an elevated risk when combined with high saturated fat consumption.
Lipid Panel
The lipid panel provides foundational data, including total cholesterol, LDL cholesterol (“bad” cholesterol), HDL cholesterol (“good” cholesterol), and triglycerides. These values help determine how saturated fat intake influences lipid balance. For example, diets high in saturated fat may increase LDL cholesterol, while also affecting triglyceride and HDL levels, which are crucial for cardiovascular health assessment.
How Healthcare Professionals Use the Cholesterol & Saturated Fat Risk Panel Results
Healthcare providers use the Cholesterol & Saturated Fat Risk Panel to develop personalized dietary and lifestyle recommendations that align with an individual's metabolic and cardiovascular risk profile. For example:
-
Elevated ApoB or LDL cholesterol may indicate a need to limit saturated fat intake, increase fiber, or consider cholesterol-lowering strategies.
-
High glucose or A1C levels signal insulin resistance, requiring carbohydrate management and lifestyle modifications to reduce overall metabolic stress.
-
Abnormal liver enzymes may lead to reducing saturated fat intake or adopting dietary interventions to prevent fatty liver disease.
-
Elevated hs-CRP calls for anti-inflammatory strategies, including increasing omega-3 intake, improving diet quality, and addressing lifestyle stressors.
-
Lipid panel results guide clinicians on whether the patient’s cholesterol ratios and triglyceride levels are improving or worsening with dietary changes.
This data-driven approach ensures that patients receive individualized guidance, avoiding one-size-fits-all recommendations and instead focusing on the unique interplay between diet, metabolism, and heart health.
Conclusion
The Cholesterol & Saturated Fat Risk Panel provides a thorough assessment of the biomarkers most affected by dietary cholesterol and saturated fat intake. By evaluating ApoB, traditional lipids, blood sugar control, liver function, and inflammation, this panel equips patients and clinicians with actionable insights to make informed dietary decisions and reduce cardiovascular risk. Whether you follow a standard diet or a high-fat approach, this panel ensures you have the data needed to protect your heart and optimize long-term health.